PureTech (PRTC LN) Successful $30m Gelesis capital raise and broad commercial progress | Verona Pharma (VRP LN) Stellar Phase II data in Cystic Fibrosis incl. improvement in lung function
02 Mar 2018
Morning Song
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
- Published:
02 Mar 2018 -
Author:
N+1 Singer Team -
Pages:
8
PureTech (PRTC LN) Successful $30m Gelesis capital raise and broad commercial progress | Verona Pharma (VRP LN) Stellar Phase II data in Cystic Fibrosis incl. improvement in lung function